Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | CA2 | P00918 | 4/20 | 0.70 |
| ▸ | CA9 | Q16790 | 4/20 | 0.70 |
| ▸ | CA12 | O43570 | 3/20 | 0.70 |
| ▸ | CA4 | P22748 | 3/20 | 0.70 |
| ▸ | CA6 | P23280 | 2/20 | 0.70 |
| ▸ | CA5A | P35218 | 2/20 | 0.70 |
| ▸ | CA7 | P43166 | 2/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.70 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.64 |
| ▸ | HTR6 | P50406 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MPO | P05164 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3956091 | 0.97 | CA1 (0.71) | CA1CA2CA9CA12CA4 | |
| SCHEMBL158288 | 0.91 | HTR6 (0.71) | CA1CA2CA9CA12CA4 | |
| SCHEMBL151654 | 0.91 | HTR6 (0.70) | CA1CA2CA9CA12CA4 | |
| SCHEMBL157205 | 0.89 | LOXL2 (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL27827976 | 0.89 | ABAT (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL28373830 | 0.89 | GAA (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL5759642 | 0.87 | LOXL2 (0.58) | CA1CA2CA9CA12CA4 | |
| Hydrochloric Acid SCHEMBL159992 | 0.87 | LOXL2 (0.64) | CA1CA2CA9CA12CA4 | |
| SCHEMBL27919766 | 0.87 | CA1 (0.55) | CA1CA2CA9CA12CA4 | |
| Dapsone SCHEMBL4106701 | 0.84 | CA2 (0.74) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1296540-B1 | DISPLAY | TORAY INDUSTRIES (JP) | 2019-10-16 | — | — | EP | disclosed |
| CN-105899511-B | Tricyclic gyrase inhibitor | 默沙东公司 | 2019-06-07 | — | — | CN | disclosed |
| CN-106536525-B | Compound | 葛兰素史密斯克莱知识产权发展有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-106536525-A | Compounds | 葛兰素史密斯克莱知识产权发展有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-105899511-A | Tricyclic gyrase inhibitors | 默沙东公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104507923-A | Substituted pyrrole active agents as kinase inhibitors | NERVIANO MEDICAL SCIENCES SRL | 2015-04-08 | — | — | CN | disclosed |
| US-7504434-B2 | Dimeric compounds and their use as anti-viral agents | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) | 2009-03-17 | — | — | US | disclosed |
| US-20070225361-A1 | DIMERIC COMPOUNDS AND THEIR USE AS ANTI-VIRAL AGENTS | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. | 2007-09-27 | — | — | US | disclosed |
| US-7214707-B2 | Dimeric compounds and their use as anti-viral agents | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) | 2007-05-08 | — | — | US | disclosed |
| CN-1267501-C | Light sensitivity resin precursor compsn. | TORAY INDUSTRIES (JP) | 2006-08-02 | — | — | CN | disclosed |
| EP-0878740-B1 | Radiation sensitive polymer composition | TORAY INDUSTRIES (JP) | 2004-11-10 | — | — | EP | disclosed |
| CN-1154708-C | Chemical-ray sensitive polymer composition | 东丽株式会社 | 2004-06-23 | — | — | CN | disclosed |
| CN-1480491-A | Light sensitivity resin precursor compsn. | ������������ʽ���� | 2004-03-10 | — | — | CN | disclosed |
| US-6696112-B2 | POSITIVE-TYPE, PHOTOSENSITIVITY; FLAT PANEL DISPLAYS | TORAY INDUSTRIES, INC. (JP) | 2004-02-24 | — | — | US | disclosed |
| EP-1296540-A1 | DISPLAY | TORAY INDUSTRIES, INC. (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-20020162998-A1 | Display | TORAY INDUSTRIES, INC. (JP) | 2002-11-07 | — | — | US | disclosed |
| CN-1201061-A | Chemical-ray sensitive polymer composition | TORAY CO LTD (JP) | 1998-12-09 | — | — | CN | disclosed |
| EP-0878740-A1 | Radiation sensitive polymer composition | TORAY INDUSTRIES, INC. (JP) | 1998-11-18 | — | — | EP | disclosed |
| EP-0495091-A4 | AICA RIBOSIDE ANALOGS | — | 1993-01-07 | — | — | EP | disclosed |
| EP-0495091-A1 | AICA RIBOSIDE ANALOGS | GENSIA, INC. (US) | 1992-07-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225361-A1 | DIMERIC COMPOUNDS AND THEIR USE AS ANTI-VIRAL AGENTS | EIF2AK2, IRF3, SARS1 | CA1 2901/4885CA2 1733/4885CA9 2397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.